FNDC5 and obesity disorder: Given that the non-glycosylated form of irisin inhibits the proinflammatory activity of adipocytes [6] and macrophages [7,8,9], we verified whether its glycosylation changes the nature of its impact on the equivalent of obesity-related meta-inflammation.